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Characterization of the differences between biological and random networks can reveal the design
principles that enable the robust realization of crucial biological functions including the establish-
ment of different cell types. Previous studies, focusing on identifying topological features that are
present in biological networks but not in random networks, have, however, provided few functional
insights. We use a Boolean modeling framework and ideas from spin glass literature to identify
functional differences between five real biological networks and random networks with similar topo-
logical features. We show that minimal frustration is a fundamental property that allows biological
networks to robustly establish cell types and regulate cell fate choice, and this property can emerge
in complex networks via Darwinian evolution. The study also provides clues regarding how the reg-
ulation of cell fate choice can go awry in a disease like cancer and lead to the emergence of aberrant
cell types.
Biological regulatory networks establish cell type-
specific gene expression patterns [1] and regulate cell
fate-choice in response to various signals. These net-
works present a contradiction analogous to the famed
Levinthal paradox in protein folding [2]. Networks as
large and complex as those regulating cell fate typically
exhibit a huge number of stable states [3]. Each such sta-
ble state or collection of stable states with a reasonably
shared pattern of gene expression represents a cell type
[4, 5]. This relationship, however, predicts a number of
cell types much larger than that seen in multicellular or-
ganisms. A smaller number of cell types can be attained
via the evolutionary fine-tuning of network parameters [6]
or by putting cells through a precise sequence of events
during development [7]. In both scenarios, cell fate will
be highly sensitive to intra- and extra-cellular perturba-
tions, an undesirable property.
Features that distinguish biological regulatory net-
works from random networks may provide a clue regard-
ing how these networks can robustly establish the smaller
than expected number of cell types. Biological networks
have been shown to often exhibit a scale-free degree dis-
tribution [8] which might allow these networks to define
topologically stable cell types [9]. Regulatory networks
in Escherichia coli and Saccharomyces cerevisiae have
been shown to be hierarchically organized [10]. Certain
network patterns, called motifs, are known to recur far
more frequently in biological networks than in random
networks [11], and often mediate cell fate choice [12].
However, these investigations of topological differences
between biological and random networks have provided
few insights into how the functional characteristics of bi-
ological networks differ from those of random networks
and allow biological networks to establish cell types. In
this Letter, we compare the dynamical behavior of bi-
ological networks with that of random networks which
have similar topological features and observe some re-
markable differences. These could hold the key to eluci-
dating the design principles that allow biological regula-
tory networks to carry out their biological functions.
Boolean modeling of biological networks.— A Boolean
modeling framework [13] has proven useful for charac-
terizing the behavior of large networks in cases where
the use of ordinary differential equations-based model-
ing frameworks becomes challenging due to the numer-
ous and hard to estimate kinetic parameters involved. In
this framework, the only knowledge required is whether
each regulatory relationship between network nodes is ac-
tivating or inhibitory. The state of a N -node network in
such a framework may be specified via a sequence {si} of
N binary variables; si = ±1. When modeling a biolog-
ical regulatory network, each network node represents a
molecular species such as a transcription factor or micro-
RNA. If species i (the molecular species represented by
node i) is highly expressed, si = +1, otherwise si = −1.
Regulatory relationships between molecular species are
specified by a N ×N matrix J where Jij = +1 of species
j promotes the expression of species i and Jij = −1 if
species j inhibits the expression of species i. The ab-
sence of any regulatory relationship between species i
and species j is indicated by Jij = 0. The discrete-time
network dynamics can then be simulated using [14]
si(t+ 1) =


+1
∑
j Jijsj > 0
−1 if
∑
j Jijsj < 0
si(t)
∑
j Jijsj = 0
(1)
The network state is updated asynchronously, i.e., at
each discrete time point, a network node is chosen at
random and its state updated using Eq. (1). Clearly, a
state {si} is a stable state of the network if si is a fixed
point of Eq. (1) for all i.
Note that the dynamical behavior of a network in
2the above modeling framework is equivalent to the zero-
temperature dynamics of an asymmetric spin glass on a
graph. Using this equivalence, we characterize an edge
i → j in state {si} as frustrated [15] if Jijsisj < 0, i.e.,
if the values of node i and node j in that state do not
follow the regulatory relationship between the two nodes.
Then, the frustration of a state can be defined as the frac-
tion of network edges that are frustrated in that state. If
a network involves regulatory relationships that conflict
with one another, all regulatory relationships cannot be
satisfied in any state. Hence, such a network will have
stable states with non-zero frustration.
Comparison of biological and random networks.— We
determined the stable states of five biological networks
taken from the literature [14, 16–19] (see Supplemental
Material [20], section II (a)) and compared the frustra-
tion of the stable states of each of these networks with
the frustration of the stable states of random networks
with topological features similar to the biological net-
work (each random network had the same total number
of nodes and edges, node in- and out-degree distribu-
tions, and the total number of activating and inhibitory
relationships between nodes in the network as the cor-
responding biological network) (Fig. 1; also see Supple-
mental Material [20], Fig. S1 and section II (b)-(c)). In
the case of each biological network, most stable states
had frustration comparable to the frustration of each of
the stable states of the corresponding random networks.
However, each biological network had a set of stable
states with frustration much lower than the frustration of
the stable states of random networks. Crucially, biolog-
ical networks are highly likely to end up in one of these
minimally frustrated stable states when their dynamics
is simulated starting from random initial conditions (Fig.
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FIG. 1. (Color online) Distribution of frustration for the sta-
ble states of biological networks and random networks. The
blue (black in print) violin in each panel shows the frustration
of the states one ends up in when simulating the dynamics of
the biological network starting from 500 random initial con-
ditions. In the case of the 72-node EMT network and in the
case of the pluripotency network, 5000 least frustrated stable
states of each random network have been shown. The white
circle in each violin indicates the median.
1: blue (black in print) violins in each panel; also see Sup-
plemental Material [20], Fig. S2). Minimally frustrated
stable states are thus likely to be biologically significant,
with most cells in a population exhibiting gene expression
patterns corresponding to these states.
Relation between stables states and biological pheno-
typic states.—We next investigated if any structural pat-
terns underlie the organization of stable states of biologi-
cal networks. The distribution P (qαβ) of the overlap be-
tween network states qαβ =
∑
i(s
α
i s
β
i )/N was found to be
very broad when α, β pairs are chosen randomly from the
set of stable states of biological networks. This indicates
a hierarchical organization of stable states [21]. However,
when the pairs are sampled from among the minimally
frustrated stable states, P (qαβ) is bimodal with peaks
near +1 and −1 (Fig. 2 (a) and 2 (d); also see Supple-
mental Material [20], Fig. S3 (a), S3 (c), and S3 (e)).
Since qαβ is a measure of similarity between the states
{sαi } and {s
β
i }, a collection of states with qαβ close to
+1 for all pairs represents a collection of cells with rea-
sonably similar gene expression profiles, to be associated
with a distinct cell phenotype. A bimodal P (qαβ) for
minimally frustrated stable states of biological networks
considered here thus suggests that these states constitute
two stable cell phenotypes.
In the case of the network regulating epithelial-
mesenchymal transition (EMT) [14], minimally frus-
trated stable states represent the two canonical pheno-
typic states, epithelial and mesenchymal (Fig. 2 (b)-(c);
also see Supplemental Material [20], Fig. S3 (b)). In the
case of the network regulating pluripotency and differ-
entiation in human embryonic stem cells [18], minimally
frustrated stable states define stem and differentiated cell
types (Fig. 2 (e)-(f)). In contrast, high frustration sta-
ble states of biological networks involve co-presentation
of molecular markers corresponding to conflicting biologi-
cal behaviors. For instance, high frustration stable states
of the network regulating EMT involve co-presentation
of epithelial and mesenchymal markers (Fig. 2 (b)-(c);
also see Supplemental Material [20], Fig. S3 (b)). Sim-
ilarly, high frustration stable states of the network reg-
ulating the neuroendocrine-mesenchymal transition [16]
involve co-presentation of neuroendocrine and mesenchy-
mal markers (see Supplemental Material [20], Fig. S3
(d)). These stable states thus represent ambiguous cell
fate choices. Such ambiguous phenotypic states have
been reported in cancer cells across disease sub-types
[16, 22], but appear to be suppressed in healthy tissue.
To relate more directly to experimental data, we note
that deletion of molecular species like GRHL2, OVOL2,
and ∆NP63α from the 26-node EMT network can lower
the frustration of network stable states and decrease the
fraction of stable states with co-presentation of epithe-
lial and mesenchymal markers (see Supplemental Mate-
rial [20], Fig. S4). Indeed, loss of expression of such
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FIG. 2. Minimally frustrated stable states of biological networks define canonical cell types. (a), (d) P (qαβ) is bimodal for
the minimally frustrated stable states of both the 72-node EMT network and the pluripotency network. (b), (c), (e), (f)
Principal component-representation of the 200000 observed stable states of the 72-node EMT network and of the pluripotency
network. In each case, we included 100000 least frustrated and 100000 most frustrated stable states. In (c), a high, positive
score indicates an epithelial phenotype while a low, negative score indicates a mesenchymal phenotype. In (f), a high, positive
score indicates a stem cell phenotype while a low, negative score indicates a differentiated phenotype. Clusters with extreme
values of the phenotypic scores represent canonical cell types. See Supplemental Material [20], section II (d) for details of how
the scores were defined.
species in cells has recently been shown to inhibit such
co-presentation [23–25].
Effect of noise in network dynamics.— So far, we have
neglected stochasticity in our analyses. Noise in gene
expression can have significant implications for cellular
function [26]. We defined a pseudo-Hamiltonian H =
−
∑
i,j Jijsisj and used the finite-temperature Metropo-
lis Monte Carlo algorithm [27, 28] to probe network be-
havior under noisy dynamics (for details of the simula-
tions, see Supplemental Material [20], section II (e)). As
node dynamics become increasingly noisy, biological net-
works become more and more likely to exhibit states with
high frustration (Fig. 3 (a) and 3 (e); also see Supplemen-
tal Material [20], Fig. S5 (a)-(c), and S6). Functionally,
this manifests as more and more cells in a population
presenting with ambiguous cell fate choices (Fig. 3 (c)
and 3 (g)).
Effect of network mutations.— Another scenario in
which cells presenting ambiguous cell fate choices are fre-
quently observed in our modeling framework is if the bi-
ological network becomes mutated (Fig. 3 (b) and 3 (f);
also see Supplemental Material [20], Fig. S5 (d)-(f), and
S7). We observed that the studied biological networks are
relatively robust, and it is only after a signifivant number
of mutations have accumulated that a significant fraction
of cells in the population start exhibiting non-canonical
phenotypic states. Since high frustration stable states
are far more numerous than minimally frustrated sta-
ble states, cell-to-cell variation in network states will be
higher when cells exhibit high frustration.
Emergence of biological characteristics in random net-
works.— Under selection for networks with low frustra-
tion states, a population of randomized 26-node EMT
networks can evolve to exhibit the behavior reported
herein for the corresponding biological network (Fig. 4;
see Supplemental Material [20], section II (f) for details
of the simulation). This includes existence of minimally
frustrated stable states that are frequently encountered
when starting from random initial conditions (Fig. 4
(Top)) and a bimodal P (qαβ) when α, β pairs are sam-
pled from among the minimally frustrated stable states
(Fig. 4 (Bottom)). That such an evolutionary process is
feasible lends crucial support to the hypothesis that the
existence of minimally frustrated stable states is a fea-
ture that has been acquired by complex biological net-
works over evolutionary time. Finally, preliminary data
suggests that one can relax the assumption of a Boolean
modeling framework without changing any of the conclu-
sions (see Supplemental Material [20], section II (g), Fig.
S8, S9 (b), and S9 (d)).
Discussion— In the energy landscape description of
protein folding [29, 30], existence of minimally frustrated
structural conformations distinguishes biological proteins
from random heteropolymers. Here, we have shown that
the existence of minimally frustrated stable states sim-
ilarly distinguishes biological regulatory networks from
random networks. These minimally frustrated stable
states represent canonical cell types and because most
random initial conditions dynamically evolve to one of
4the minimally frustrated stable states, biological net-
works can robustly establish cell types and regulate cell
fate choice between these types. The number of com-
monly observed cell fates is thus limited to the number of
expression patterns in these minimally frustrated stable
states. The minimal frustration property distinguishes
stable states corresponding to canonical cell types from
other possible stable states of the biological network. In
contrast, while a random network may have a collection
of stable states with an expression pattern similar to that
of a canonical cell type, these stable states will in no
way be special as compared to the numerous other stable
states the random network can exhibit.
Cancer cells exhibit very noisy gene expression which
may be driven by the overexpression of certain genes [31–
33], corrupted epigenetic regulation [34], or by metabolic
re-programming [35]. Our results suggest that given the
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FIG. 3. (Color online) High frustration states are increasingly
occupied under noisy dynamics or if the biological network ac-
cumulates mutations. (a), (e) Frustration of observed biologi-
cal network states under noisy node dynamics. The dynamics
become more and more noisy as the pseudo-temperature is
increased. (b), (f) Frustration of observed states when muta-
tions are introduced into biological networks (without noise in
the network dynamics). (c), (d) Epithelial scores of observed
states under different levels of noise in the network dynamics
(c) and when the network is mutated (d). (g), (h) Stemness
scores of observed states under different levels of noise (g) and
when the network is mutated (h). The white circle in each
violin indicates the median.
high gene expression noise, cancer cells must frequently
exhibit ambiguous cell fate choices. Such behavior has
been reported across cancer subtypes, and non-canonical
phenotypic states in cancer cells have been shown to be
associated with disease aggressiveness. For example, hy-
brid epithelial-mesenchymal cells, reported across cancer
types, have been implicated in the metastatic aggressive-
ness of solid tumors [22]. Also, populations of small cell
lung cancer cells treated with anti-cancer drugs have been
shown to enrich for hybrid neuroendocrine-mesenchymal
cells [16]. Lowering of network frustration upon dele-
tion from the EMT network of factors known to stabi-
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FIG. 4. (Color online) Evolution of biological behavior by a
population of random networks under selection for networks
with low frustration states. (Top) Frustration of the least
frustrated observed state averaged over the networks in a
population of 500 networks. Different curves indicate inde-
pendent simulation runs. (Inset) State frustration averaged
over the end states of simulations starting from 50 random
initial conditions for each network followed by averaging over
the networks in the population. The initial population of 500
random networks was generated from the 26-node EMT net-
work. (Bottom) P (qαβ) at different time points during the
evolution simulation, shown for one of the simulation runs.
5lize hybrid epithelial-mesenchymal cells (shown in Sup-
plemental Material [20], Fig. S4) further bolsters the
evidence for a connection between non-canonical pheno-
typic states and high frustration in biological networks.
Our model thus provides a new perspective on how noise
in the dynamics of regulatory networks in cancer cells can
contribute towards the failure of anti-cancer therapies—
noise can facilitate the emergence of cancer cells that
exhibit non-canonical phenotypic states. Additionally,
accumulation of mutations in biological networks, an-
other characteristic associated with cancer progression,
will also promote aberrant cell fate choice. Both noisy
gene expression and accumulation of mutations have been
shown to be key contributors to intra-tumoral hetero-
geneity, with significant implications for the failure of
anti-cancer therapies [36]. Estimation of network frus-
tration from cancer cell gene expression data will be a
direct test of the role of cell fates associated with high
frustration states in disease aggressiveness.
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